RARE vs TTI · rev $560.2M vs P/E 170, $1.50B cap
Ultragenyx (RARE) versus Tetra Technologies Inc (TTI) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Tetra Technologies Inc (TTI) is a conglomerates company listed on NYSE.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
TTI does not have a complete income-statement cache yet.
RARE currently screens at market cap $2.79B. TTI currently screens at market cap $1.50B and trailing P/E 169.5.
Not investment advice. Open the RARE and TTI stock pages for the full models.
Not investment advice.